Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

NCT01323790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-Induced Constipation (OIC)

Interventions

DRUG: NKTR-118
DRUG: NKTR-118
DRUG: Placebo

Sponsor

AstraZeneca